GR1000719B - Μεθοδος παρασκευης της (s)-α-εθυλ-2-οξο-1-πυρρολιδινοακεταμιδης. - Google Patents

Μεθοδος παρασκευης της (s)-α-εθυλ-2-οξο-1-πυρρολιδινοακεταμιδης.

Info

Publication number
GR1000719B
GR1000719B GR890100769A GR890100769A GR1000719B GR 1000719 B GR1000719 B GR 1000719B GR 890100769 A GR890100769 A GR 890100769A GR 890100769 A GR890100769 A GR 890100769A GR 1000719 B GR1000719 B GR 1000719B
Authority
GR
Greece
Prior art keywords
oxo
ethyl
pyrrolidineacetamide
preparing
pyrrolidinoacetamide
Prior art date
Application number
GR890100769A
Other languages
English (en)
Other versions
GR890100769A (en
Inventor
Eric Cossement
Jean-Pierre Geerts
Jean Gobert
Genevieve Motte
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of GR890100769A publication Critical patent/GR890100769A/el
Publication of GR1000719B publication Critical patent/GR1000719B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

H εν λόγω ένωση παρασκευάζεται δι' υδρογονολύσεως της (S)-α-2-(μεθυλθειο)αιθυλ]-2-οξο-1-πυρρολιδινοακεταμίδης παρουσία ενός αντιδραστηρίου αποθειώσεως όπως NaBH4/NiCl26H2O, το νικέλιο κατα Raney W-2 ή, κατά προτίμηση, το νικέλιο κατά Raney T-1. Η (S)-α-αιθυλ-2-οξο-1-πυρρολιδινοακεταμίδη είναι χρήσιμη για την αγωγή και πρόληψη υποξαιμικού και ισχαιμικού τύπου προσβολών του κεντρικού νευρικού συστήματος. ω
GR890100769A 1988-11-23 1989-11-20 Μεθοδος παρασκευης της (s)-α-εθυλ-2-οξο-1-πυρρολιδινοακεταμιδης. GR1000719B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888827389A GB8827389D0 (en) 1988-11-23 1988-11-23 Process for preparation of(s)alpha-ethyl-2-oxo-1-pyrrolidineacetamide

Publications (2)

Publication Number Publication Date
GR890100769A GR890100769A (en) 1990-12-31
GR1000719B true GR1000719B (el) 1992-11-23

Family

ID=10647345

Family Applications (1)

Application Number Title Priority Date Filing Date
GR890100769A GR1000719B (el) 1988-11-23 1989-11-20 Μεθοδος παρασκευης της (s)-α-εθυλ-2-οξο-1-πυρρολιδινοακεταμιδης.

Country Status (17)

Country Link
KR (1) KR0157610B1 (el)
CN (1) CN1020604C (el)
AT (1) AT392781B (el)
BG (1) BG51041A3 (el)
CY (1) CY1672A (el)
ES (1) ES2023532A6 (el)
FI (1) FI91961C (el)
GB (2) GB8827389D0 (el)
GR (1) GR1000719B (el)
HK (1) HK102492A (el)
HU (1) HU204508B (el)
NO (1) NO173823C (el)
PH (1) PH26332A (el)
PL (1) PL161781B1 (el)
PT (1) PT92365B (el)
RU (1) RU1797607C (el)
SG (1) SG89392G (el)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9319732D0 (en) 1993-09-24 1993-11-10 Ucb Sa Use of (s)-alpha-ethyl-2-oxo-l-pyrrolidineacetamide for the treatment of anxiety
US6107492A (en) * 1998-05-08 2000-08-22 Ucb, S.A. Process for the preparation of levetiracetam
ES2287039T3 (es) 1999-12-01 2007-12-16 Ucb, S.A. Un derivado de pirrolidinacetamida para el tratamiento de dolor cronico o neuropatico.
GB0004297D0 (en) 2000-02-23 2000-04-12 Ucb Sa 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses
US7132552B2 (en) * 2003-02-03 2006-11-07 Teva Pharmaceutical Industries, Ltd. Process for producing levetiracetam
ES2214147B1 (es) * 2003-02-28 2005-10-01 Farma-Lepori S.A. Procedimiento de obtencion de un agente antiepileptico.
PL1667967T3 (pl) 2003-09-24 2012-11-30 Ucb Pharma Sa Sposób wytwarzania pochodnych 2-okso-1-pirolidyny
CA2488325C (en) 2004-11-22 2010-08-24 Apotex Pharmachem Inc. Improved process for the preparation of (s)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide and (r)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide
AU2006254336B9 (en) 2005-06-01 2013-02-28 Ucb Pharma, S.A. 2 -oxo-I -pyrrolidine derivatives/ processes for preparing them and their therapeutic use on the central nervous system
US8338621B2 (en) 2005-12-21 2012-12-25 Ucb S.A. Process for the preparation of 2-oxo-1-pyrrolidine derivatives
WO2009050735A1 (en) * 2007-10-15 2009-04-23 Lupin Limited A novel polymorph of levetiracetam and a process for its preparation
EP2147911A1 (en) 2008-07-24 2010-01-27 ZaCh System S.p.A. Process for the preparation of levetiracetam
US7939676B2 (en) 2009-09-17 2011-05-10 Zach System S.P.A. Process for the preparation of levetiracetam
KR102461134B1 (ko) 2014-01-21 2022-10-28 얀센 파마슈티카 엔.브이. 대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도
UA121965C2 (uk) 2014-01-21 2020-08-25 Янссен Фармацевтика Нв Комбінації, які містять позитивні алостеричні модулятори або ортостеричні агоністи метаботропного глутаматергічного рецептора 2 підтипу, та їх застосування

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1309692A (en) * 1970-02-13 1973-03-14 Ucb Sa N-substituted lactams
GB8412358D0 (en) * 1984-05-15 1984-06-20 Ucb Sa Pharmaceutical composition
GB8412357D0 (en) * 1984-05-15 1984-06-20 Ucb Sa Pharmaceutical composition

Also Published As

Publication number Publication date
NO894649L (no) 1990-05-25
GB8926244D0 (en) 1990-01-10
PH26332A (en) 1992-04-29
PT92365B (pt) 1995-07-18
BG51041A3 (en) 1993-01-15
GB8827389D0 (en) 1988-12-29
RU1797607C (ru) 1993-02-23
NO173823B (no) 1993-11-01
KR900007797A (ko) 1990-06-02
HK102492A (en) 1992-12-24
NO173823C (no) 1994-02-09
AT392781B (de) 1991-06-10
ATA266689A (de) 1990-11-15
NO894649D0 (no) 1989-11-22
GR890100769A (en) 1990-12-31
CN1042904A (zh) 1990-06-13
HU204508B (en) 1992-01-28
ES2023532A6 (es) 1992-01-16
FI91961C (fi) 1994-09-12
PL161781B1 (en) 1993-07-30
GB2225322A (en) 1990-05-30
CY1672A (en) 1993-05-14
GB2225322B (en) 1992-03-25
FI91961B (fi) 1994-05-31
SG89392G (en) 1992-12-04
PT92365A (pt) 1990-05-31
KR0157610B1 (ko) 1998-11-16
HU896132D0 (en) 1990-02-28
HUT53072A (en) 1990-09-28
CN1020604C (zh) 1993-05-12
FI895562A0 (fi) 1989-11-22

Similar Documents

Publication Publication Date Title
GR1000719B (el) Μεθοδος παρασκευης της (s)-α-εθυλ-2-οξο-1-πυρρολιδινοακεταμιδης.
NO931635L (no) Fremgangsmaate for fremstilling av kinazolin-derivater
AU6760987A (en) Method of treating alzheimer's disease
MY131298A (en) 5-heteroyl indole derivatives
IS4226A (is) Hliðstæðar aðferðir við framleiðslu á nýjum (R)-5-karbamóýl-8-flúor-3-N,N-tvíútskiptum-amínó-3,4-díhýdró-2H-1-bensópýrönum
DE69637730D1 (de) Verfahren zur in vito vorbehandlung von myoblasten vor deren transplantation
AU1694392A (en) Determination of motifs of peptides on mhc molecules
ATE317912T1 (de) Verfahren zur herstellung von beta-lactamen
ES2063202T3 (es) Nuevas 5,11-dihidro-6h-dipirido(3,2-b:2',3'-e)(1,4)diazepin-6-onas y -tionas y su uso en la prevencion o tratamiento del sida.
ES2117976T3 (es) Preparacion de derivados n-acetil neuraminicos.
AU4780285A (en) 1-substituted tetralin derivatives, their preparation and their use
FI925649A0 (fi) Karboxivinylpolymerer med newtonsk viskositet
ES2080140T3 (es) Derivados de eritromicina.
ES2001875A6 (es) Procedimiento para preparar nuevos derivados de aminoacidos
GR1000156B (el) ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ ΝΕΩΝ ΠΑΡΑΓΩΓΩΝ ΤΡΙΚΥΚΛΙΚΩΝ ΑΜΙΝΩΝ ΤΗΣ ΤΕΤΡΑΥΔΡΟ-5,6,7,8ΝΑΦΘΟ[2,3b] ΔΙΥΔΡΟ-2,3 ΦΟΥΡΑΝΗΣ & ΤΗΣ ΤΕΤΡΑΥΔΡΟ-6,7,8,9 5Η-ΒΕΝΖΟΚΥΚΛΟΕΠΤΑ[2,3Β] ΔΙΥΔΡΟ-2,3 ΦΟΥΡΑΝΗΣ.
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
DK0444853T3 (da) Hexahydrobenz(cd)indoler
OA09352A (fr) "Méthode de préparation de dérivés de furo (3,4-c) pyridine sous forme non-racémique".
MY107354A (en) Substituted cyclohexenes as central nervous system agents
DK0391185T3 (da) 1,8-Naphthyridiner
WO1988003150A3 (fr) Preparations aminoacides contenant des peptides de n,n'-bis-l-aminoacide-l-cystine et destinees a l'administration orale et parenterale
ATE152722T1 (de) Verfahren zur herstellung von 9-(2-hydroxy)- ethoxy-guanin
IT8820117A0 (it) Procedimento per la preparazione di bis(2,2,6,6_tetrametil_4_piperidil)ammina.
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
AU7025087A (en) Pharmaceutical compositions for the therapy of cerebropathies on functional and organic base

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees